Diagnostic and treatment delay in extrapulmonary tuberculosis and association with mortality: Experiences from Mbeya, Tanzania
PLOS ONE · 2025
DOI: 10.1371/journal.pone.0320691 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS ONE, 2025. Verfasst von Erlend Grønningen und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Global Public Health and Primary Care, Centre for International Health, University of Bergen, Bergen, Norway. Hauptthemen laut MEDLINE: Tuberculosis, Delayed Diagnosis, Time-to-Treatment. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Norges Forskningsråd, European and Developing Countries Clinical Trials Partnership, Helse Vest.
Abstract (Originalsprache)
Background
Unlike pulmonary tuberculosis, there is limited information on delays in diagnosis and treatment initiation in extrapulmonary tuberculosis (EPTB) and their consequences for disease outcomes and mortality. In low- and middle-income countries, most EPTB cases are presumed rather than microbiologically confirmed, which might lead to an underestimation of the mortality rates in EPTB.
Objective
The study aimed to assess the delays in diagnosis and treatment in EPTB and their association with mortality in a setting with a high prevalence of both HIV and malnutrition.
Method
We included 106 EPTB patients from Mbeya Zonal Referral Hospital, who were followed up until the completion of their treatment. Patients were classified as having EPTB using a clinical case definition. In total, 37 of 106 (35%) EPTB cases resulted in death. The median (interquartile range) total diagnostic delay for survivors was 59 days (26-136), while for those who died, it was 78 days (32-165). The corresponding median (interquartile range) treatment delay was 66 days (33-140) for survivors and 78 days (27-189) for those who died. None of the differences reached statistical significance when analyzed with non-parametric tests. Surprisingly, 21 patients did not receive TB treatment, but this lack of therapy did not affect mortality or correlate with a longer diagnostic delay.
Conclusion
We were unable to demonstrate that diagnostic or treatment delays were higher in EPTB patients who died. Furthermore, EPTB patients who did not receive TB treatment did not exhibit higher mortality rates. Further prospective studies with larger sample sizes are needed to better understand the factors contributing to delays in diagnosis and treatment, as well as their potential impact on mortality in EPTB.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Global Public Health and Primary Care, Centre for International Health, University of Bergen, Bergen, Norway.
- Department of Thoracic Medicine, Haukeland University Hospital, Bergen, Norway.
- National Institute for Medical Research, Muhimbili Medical Research Centre, Dar es Salaam, The United Republic of Tanzania.
ORCID-Profile: Erlend Grønningen
Förderung
- Norges Forskningsråd
- European and Developing Countries Clinical Trials Partnership
- Helse Vest
Zitieren
APA
Grønningen, E., Nanyaro, M., Ngadaya, E., & Mustafa, T. (2025). Diagnostic and treatment delay in extrapulmonary tuberculosis and association with mortality: Experiences from Mbeya, Tanzania. PLOS ONE. https://doi.org/10.1371/journal.pone.0320691
Vancouver
Grønningen E, Nanyaro M, Ngadaya E, Mustafa T. Diagnostic and treatment delay in extrapulmonary tuberculosis and association with mortality: Experiences from Mbeya, Tanzania. PLOS ONE. 2025. doi:10.1371/journal.pone.0320691
BibTeX
@article{Grnningen2025,
author = {Grønningen, Erlend and Nanyaro, Marywinnie and Ngadaya, Esther and Mustafa, Tehmina},
title = {Diagnostic and treatment delay in extrapulmonary tuberculosis and association with mortality: Experiences from Mbeya, Tanzania},
journal = {PLOS ONE},
year = {2025},
doi = {10.1371/journal.pone.0320691}
}
EUVIMED